Scientists at the La Jolla Institute for Immunology (LJI) in California have achieved a significant breakthrough, becoming the first in…
Read More
Bioengineered Bone Marrow-on-a-chip Platform Developed by Penn Researchers Offers New Frontiers for Cancer Treatment and Space Medicine
Researchers from the University of Pennsylvania’s School of Engineering and Applied Science, the Perelman School of Medicine, and the Children’s…
Read More
Pioneering Unconventional Drug Delivery Systems Transform Cancer Treatment Landscape
The effectiveness of groundbreaking therapeutic agents is intrinsically linked to their successful and precise delivery within the human body. Without…
Read More
FDA Approves Langlara, an Interchangeable Biosimilar for Diabetes Management, Expanding Patient Access and Treatment Options
Sunshine Lake Pharma, Lannett Company, and its wholly owned subsidiary Lanexa Biologics have achieved a significant milestone in diabetes care…
Read More
Canadian Researchers Identify Potential Breakthrough in Glioblastoma Treatment Using Repurposed HIV Medication
A collaborative team of scientists from McMaster University and The Hospital for Sick Children (SickKids) has uncovered a significant biological…
Read More
Johns Hopkins Researchers Identify Key Protein and Gas Signaling Pathway as Potential Target for Alzheimer’s Disease Treatment
Researchers at Johns Hopkins Medicine have unveiled a significant breakthrough in the understanding of Alzheimer’s disease, identifying a specific protein…
Read More
Chiesi Acquires KalVista Pharmaceuticals for $1.9 Billion, Bolstering Rare Disease Portfolio with On-Demand HAE Treatment
In a landmark move that marks the largest acquisition in its 90-year history, Italian pharmaceutical giant Chiesi has agreed to…
Read More
LEO Pharma Acquires Gene Therapy Pioneer Replay to Revolutionize Treatment for Rare Genetic Dermatological Diseases
In a landmark move poised to redefine the landscape of dermatological therapeutics, LEO Pharma, a global leader in medical dermatology,…
Read More
Researchers Uncover Glioblastoma’s Systemic Impact on the Skull and Immune System Challenging Current Treatment Paradigms
A groundbreaking study led by researchers from the Montefiore Einstein Comprehensive Cancer Center (MECCC) and the Albert Einstein College of…
Read More
FDA Approves Auvelity for Alzheimer’s Disease Agitation, Offering a Novel Treatment Option
The U.S. Food and Drug Administration (FDA) has granted approval to Axsome Therapeutics’ Auvelity (dextromethorphan HBr and bupropion HCl) for…
Read MoreYOU MAY HAVE MISSED
